Spain
Founded in 2014, Aniling is a spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), which is currently integrated into the Germans Trias i Pujol Biomedical Research Institute (IGTP). The company has established its offices and laboratories within the IGTP and has full access to the shared resources and facilities of the Can Ruti Campus. This collaborative environment includes the Hospital Germans Trias i Pujol, the Autonomous University of Barcelona, and five biomedical research institutes, comprising IGTP, IRSICaixa, IJC, Guttmann Institute, and ICO.
Aniling operates in the Biotechnology, Health Care, and Life Sciences industries, positioning itself at the intersection of cutting-edge technology and healthcare innovation. Although no information is available regarding last investment or last investment investors, the company's strategic collaboration within a prominent research ecosystem showcases its potential for impactful growth and technological advancement in the field of precision medicine.
